Inventor
ADAMSON JUSTUS
US13 patents
⚠️ This page may combine multiple inventors who share the name “ADAMSON JUSTUS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IMMUNOLIGHT LLC
12 patentsUS10596387B2Mar 24, 2020
Tumor imaging with X-rays and other high energy sources using as contrast agents photon-emitting phosphors having therapeutic properties
IMMUNOLIGHT LLC13 citations84
US11260129B2Mar 1, 2022
Phosphor-containing drug activator, suspension thereof, system containing the suspension, and methods for use
IMMUNOLIGHT LLC2 citations72
US11207409B2Dec 28, 2021
X-RAY psoralen activated cancer therapy (X-PACT) with associated treatments
IMMUNOLIGHT LLC3 citations70
US10441810B2Oct 15, 2019
X-ray psoralen activated cancer therapy (X-PACT)
IMMUNOLIGHT LLC3 citations70
US12226483B2Feb 18, 2025
Phosphor-containing drug activator, suspension thereof, system containing the suspension, and methods for use
IMMUNOLIGHT LLC0 citations62
US11865359B2Jan 9, 2024
Tumor imaging with x-rays and other high energy sources using as contrast agents photon-emitting phosphors having therapeutic properties
IMMUNOLIGHT LLC1 citations62
US11786595B2Oct 17, 2023
Methods for radiotherapy to trigger light activation drugs
IMMUNOLIGHT LLC1 citations62
US11135294B2Oct 5, 2021
Methods for radiotherapy to trigger light activation drugs
IMMUNOLIGHT LLC1 citations62
US10940329B2Mar 9, 2021
Phosphor-containing drug activator activatable by a Monte Carlo derived x-ray exposure, system containing the activator, and methods for use
IMMUNOLIGHT LLC1 citations62
US11577092B2Feb 14, 2023
Phosphor-containing drug activator activatable by a monte carlo derived X-ray exposure, system containing the activator, and methods for use
IMMUNOLIGHT LLC1 citations61
US11992697B2May 28, 2024
X-ray psoralen activated cancer therapy (X-PACT)
IMMUNOLIGHT LLC0 citations60
US11305131B2Apr 19, 2022
X-ray psoralen activated cancer therapy (X-PACT)
IMMUNOLIGHT LLC1 citations60